desk
Share
News Topical, Digital Desk : Gujarat-based Torrent Pharmaceuticals Limited is once again in talks with private equity firm KKR to buy a 47.84 per cent stake in JB Chemicals and Pharmaceuticals (JB Pharma). According to a Moneycontrol report, the deal between the two parties may happen soon. Last year, Torrent Pharma was in talks to acquire JB Pharma but the deal was canceled due to differences over valuation. KKR bought 54 per cent stake in JB Pharma in July 2020 for around Rs 3,100 crore, which was at Rs 745 per share. In March 2025, KKR reduced it to 47.84 per cent by selling some of its stake through a block deal.
Based on JB Pharma's closing price of ₹1,802.9 per share on June 27, the current value of KKR's stake is now around ₹13,400 crore. In case of a deal, it will be mandatory for public shareholders to make an open offer for 26 percent stake in the company. According to the report, KKR has not commented on this, while emails sent to Torrent Pharma and JB Pharma did not receive a response. Company acquisitions The company acquired Elder Pharma's Indian branded business in 2013. After this, it bought Zyg Pharma's dermaceutical business in 2015. In 2016, Torrent acquired Glochem Industries' API plant. Then in 2017, it acquired Unichem's Indian branded business and its Sikkim plant along with women's healthcare brands from Novartis. Torrent's biggest acquisition came in 2022, when it bought Curatio Healthcare for around ₹2,000 crore.
--Advertisement--
